We are live on ! Find out more
CORT icon

Corcept Therapeutics
CORT

273 hedge funds and large institutions have $2.79B invested in Corcept Therapeutics in 2023 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 82 increasing their positions, 93 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 26

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

23% more capital invested

Capital invested by funds: $2.26B → $2.79B (+$531M)

22% more call options, than puts

Call options by funds: $49.6M | Put options by funds: $40.6M

11% more funds holding

Funds holding: 246 → 273 (+27)

3.07% more ownership

Funds ownership: 80.41% → 83.49% (+3.1%)

12% less repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 93

Holders
273
Holders Change
+27
Holders Change %
+10.98%
% of All Funds
3.98%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
56
Increased
82
Reduced
93
Closed
26
Calls
$49.6M
Puts
$40.6M
Net Calls
+$8.97M
Net Calls Change
+$3.98M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$37.5M
2
BlackRock
BlackRock
New York
+$33.2M
3
Man Group
Man Group
United Kingdom
+$22.7M
4
IECM
Intrinsic Edge Capital Management
Illinois
+$12.8M
5
QC
Quantedge Capital
Singapore
+$6.82M

Top Sellers

1
NHAS
Novo Holdings A/S
Denmark
-$26.5M
2
GIP
Granite Investment Partners
California
-$13.4M
3
Cerity Partners
Cerity Partners
New York
-$12M
4
Invesco
Invesco
Georgia
-$7.4M
5
Northern Trust
Northern Trust
Illinois
-$5.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
MA
276
Mutual Advisors
Nebraska
– -$939K -34,462 Closed
CWA
277
Clearview Wealth Advisors
Oregon
– -$688K -25,258 Closed
ECM
278
ExodusPoint Capital Management
New York
– -$677K -24,832 Closed
Baird Financial Group
279
Baird Financial Group
Wisconsin
– -$634K -23,274 Closed
WB
280
WesBanco Bank
West Virginia
– -$631K -23,152 Closed
MML Investors Services
281
MML Investors Services
Massachusetts
– -$558K -20,479 Closed
DFCM
282
Dark Forest Capital Management
Puerto Rico
– -$528K -19,384 Closed
Marshall Wace
283
Marshall Wace
United Kingdom
– -$519K -19,042 Closed
BCM
284
Bayesian Capital Management
New York
– -$338K -12,409 Closed
CF
285
Cantor Fitzgerald
New York
– -$330K -12,112 Closed
IFG
286
Independent Financial Group
California
– -$240K -8,825 Closed
VF
287
Virtu Financial
New York
– -$227K -8,324 Closed
FRM
288
Fox Run Management
Connecticut
– -$220K -8,085 Closed
YIH
289
Y-Intercept (HK)
Hong Kong
– -$212K -7,765 Closed
Commonwealth Equity Services
290
Commonwealth Equity Services
Massachusetts
– -$202K -7,429 Closed
Capstone Investment Advisors
291
Capstone Investment Advisors
New York
– -$201K -7,367 Closed
GC
292
Guggenheim Capital
Illinois
– -$205K -6,540 Closed
SPIA
293
Steward Partners Investment Advisory
New York
– -$77.7K -2,853 Closed
NICM
294
Neo Ivy Capital Management
New York
– -$66K -2,424 Closed
Qube Research & Technologies (QRT)
295
Qube Research & Technologies (QRT)
United Kingdom
– -$54.7K -2,009 Closed
Point72 Asset Management
296
Point72 Asset Management
Connecticut
– -$46K -1,690 Closed
AS
297
Altshuler Shaham
Israel
– -$19.8K -728 Closed
CSPIA
298
Cary Street Partners Investment Advisory
Virginia
– -$6.81K -250 Closed
FAM
299
Flaharty Asset Management
Florida
– -$5.45K -200 Closed
8 9 10 11
12

CORT Hedge Fund Activity: Q4 2023 in Review

273 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q4 2023, worth a combined $2.79B — up 23% from $2.26B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new CORT positions and 26 closed out — a net gain of 30 holders — while 82 added to existing stakes and 93 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $37.5M. The largest seller was Novo Holdings A/S, cutting an estimated $26.5M.

  • 273 institutional investors held Corcept Therapeutics (CORT) as of Q4 2023, up from 246 in Q3 2023.
  • Funds reported $2.79B of Corcept Therapeutics stock for Q4 2023, up 23% quarter-over-quarter.
  • 56 funds opened new Corcept Therapeutics positions in Q4 2023 and 26 closed out, a net change of +30 holders.
  • The largest Corcept Therapeutics buyer in Q4 2023 was Morgan Stanley, an estimated $37.5M added.
  • The largest Corcept Therapeutics seller in Q4 2023 was Novo Holdings A/S, an estimated $26.5M sold.

Based on aggregated 13F filings for Q4 2023.